Skip to main content

Peer Review reports

From: Resveratrol activates MAPK/ERK pathway to regulate oestrogen metabolism in type I endometrial cancer

Original Submission
30 Apr 2023 Submitted Original manuscript
8 Jun 2023 Author responded Author comments - Bei Zhang
Resubmission - Version 2
8 Jun 2023 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
5 Oct 2023 Reviewed Reviewer Report
7 Oct 2023 Reviewed Reviewer Report - Saad Mustafa
30 Nov 2023 Author responded Author comments - Bei Zhang
Resubmission - Version 5
30 Nov 2023 Submitted Manuscript version 5
10 Dec 2023 Author responded Author comments - Bei Zhang
Resubmission - Version 6
10 Dec 2023 Submitted Manuscript version 6
24 Jan 2024 Reviewed Reviewer Report - Saad Mustafa
30 Jan 2024 Reviewed Reviewer Report
8 Mar 2024 Author responded Author comments - Bei Zhang
Resubmission - Version 7
8 Mar 2024 Submitted Manuscript version 7
11 Mar 2024 Author responded Author comments - Bei Zhang
Resubmission - Version 8
11 Mar 2024 Submitted Manuscript version 8
Publishing
21 May 2024 Editorially accepted
11 Jun 2024 Article published 10.1186/s12906-024-04509-y

You can find further information about peer review here.

Back to article page